Literature DB >> 28603121

Evaluation of in vitro antidiabetic and antioxidant characterizations of Elettaria cardamomum (L.) Maton (Zingiberaceae), Piper cubeba L. f. (Piperaceae), and Plumeria rubra L. (Apocynaceae).

Afnan Sh Ahmed1, Qamaruddin Ahmed2, Anil Kumar Saxena1, Parveen Jamal3.   

Abstract

Inhibition of intestinal α-amylase and α-glucosidase is an important strategy to regulate diabetes mellitus (DM). Antioxidants from plants are widely regarded in the prevention of diabetes. Fruits of Elettaria cardamomum (L.) Maton (Zingiberaceae) and Piper cubeba L. f. (Piperaceae) and flowers of Plumeria rubra L. (Apocynaceae) are traditionally used to cure DM in different countries. However, the role of these plants has been grossly under reported and is yet to receive proper scientific evaluation with respect to understand their traditional role in the management of diabetes especially as digestive enzymes inhibitors. Hence, methanol and aqueous extracts of the aforementioned plants were evaluated for their in vitro α-glucosidase and α-amylase inhibition at 1 mg/mL and quantification of their antioxidant properties (DPPH, FRAP tests, total phenolic and total flavonoids contents). In vitro optimization studies for the extracts were also performed to enhance in vitro biological activities. The % inhibition of α-glucosidase by the aqueous extracts of the fruits of E. cardamomum, P. cubeba and flowers of P. rubra were 10.41 (0.03), 95.19 (0.01), and -2.92 (0.03), while the methanol extracts exhibited % inhibition 13.73 (0.02), 92.77 (0.01), and -0.98 (0.01), respectively. The % inhibition of α-amylase by the aqueous extracts were 82.99 (0.01), 64.35 (0.01), and 20.28 (0.02), while the methanol extracts displayed % inhibition 39.93 (0.01), 31.06 (0.02), and 39.40 (0.01), respectively. Aqueous extracts displayed good in vitro antidiabetic and antioxidant activities. Moreover, in vitro optimization experiments helped to increase the α-glucosidase inhibitory activity of E. cardamomum. Our findings further justify the traditional claims of these plants as folk medicines to manage diabetes, however, through digestive enzymes inhibition effect.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28603121

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  5 in total

Review 1.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

Review 2.  Critical Review on Nutritional, Bioactive, and Medicinal Potential of Spices and Herbs and Their Application in Food Fortification and Nanotechnology.

Authors:  Debopriya Mandal; Tanmay Sarkar; Runu Chakraborty
Journal:  Appl Biochem Biotechnol       Date:  2022-10-11       Impact factor: 3.094

Review 3.  Ethnomedicinal Value of Antidiabetic Plants in Bangladesh: A Comprehensive Review.

Authors:  Md Masudur Rahman; Md Josim Uddin; A S M Ali Reza; Abu Montakim Tareq; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Plants (Basel)       Date:  2021-04-08

Review 4.  The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review.

Authors:  Roghayeh Yahyazadeh; Mahboobeh Ghasemzadeh Rahbardar; Bibi Marjan Razavi; Gholamreza Karimi; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

5.  The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial.

Authors:  Mohadeseh Aghasi; Shohreh Ghazi-Zahedi; Fariba Koohdani; Fereydoun Siassi; Ensieh Nasli-Esfahani; Ali Keshavarz; Mostafa Qorbani; Hoorieh Khoshamal; Asma Salari-Moghaddam; Gity Sotoudeh
Journal:  BMC Complement Altern Med       Date:  2018-01-17       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.